- Home
- CFFI vs FENC Comparison
CFFI vs FENC Comparison
Compare CFFI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- FENC
- Stock Information
- Founded
- CFFI 1927
- FENC 1996
- Country
- CFFI United States
- FENC United States
- Employees
- CFFI N/A
- FENC N/A
- Industry
- CFFI Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFFI Finance
- FENC Health Care
- Exchange
- CFFI Nasdaq
- FENC Nasdaq
- Market Cap
- CFFI 218.0M
- FENC 234.9M
- IPO Year
- CFFI 1998
- FENC 2001
- Fundamental
- Price
- CFFI $67.09
- FENC $8.99
- Analyst Decision
- CFFI
- FENC Strong Buy
- Analyst Count
- CFFI 0
- FENC 2
- Target Price
- CFFI N/A
- FENC $13.50
- AVG Volume (30 Days)
- CFFI 4.8K
- FENC 69.3K
- Earning Date
- CFFI 10-23-2025
- FENC 11-12-2025
- Dividend Yield
- CFFI 2.67%
- FENC N/A
- EPS Growth
- CFFI 42.60
- FENC N/A
- EPS
- CFFI 8.11
- FENC N/A
- Revenue
- CFFI $125,432,000.00
- FENC $33,302,000.00
- Revenue This Year
- CFFI N/A
- FENC N/A
- Revenue Next Year
- CFFI N/A
- FENC $64.79
- P/E Ratio
- CFFI $8.50
- FENC N/A
- Revenue Growth
- CFFI 9.28
- FENC N/A
- 52 Week Low
- CFFI $53.14
- FENC $3.96
- 52 Week High
- CFFI $89.90
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- CFFI 46.22
- FENC 52.62
- Support Level
- CFFI $66.78
- FENC $8.31
- Resistance Level
- CFFI $70.00
- FENC $9.03
- Average True Range (ATR)
- CFFI 0.91
- FENC 0.38
- MACD
- CFFI 0.16
- FENC 0.00
- Stochastic Oscillator
- CFFI 28.15
- FENC 55.91
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.